New Milestone Achieved! Fibocom's Fx550 5G Module Based on Samsung Exynos Modem Enters Global Mass Production
SHENZHEN, China, March 31, 2026 /PRNewswire/ -- On March 31, Fibocom announced that its Fx550 5G module (including FM550 M.2 form factor and FG550 LGA form factor), developed based on the Samsung Exynos Modem chipset, has officially entered...
Alteogen Enters into a License Agreement with Biogen for Development and Commercialization of Hybrozyme™-Based Subcutaneous Biologics
- Biogen gains rights to develop and commercialize subcutaneous (SC) formulations for two products utilizing ALT-B4 DAEJEON, South Korea, March 25, 2026 /PRNewswire/ -- Alteogen Inc. (KOSDAQ: 196170) announced today that it has entered into an...
Banyan Group Enters the United States with Banyan Tree Residences West Palm Beach
Developed in collaboration with Mast Capital and Curated JCZM Development, the project marks the U.S. debut of Banyan Group's flagship Banyan Tree brand through its first residential offering in one of the country's fastest-evolving real estate...
Databricks Enters Security Market with Launch of Lakewatch: New Open, Agentic SIEM
New product enables unlimited and unified data, petabyte-scale threat detection and investigations at up to 80% lower TCO SAN FRANCISCO, March 24, 2026 /PRNewswire/ -- Databricks, the Data and AI company, today announced Lakewatch, a new open,...
Everest Medicines Enters into Asset Purchase Agreement with Corxel Pharmaceuticals to Develop and Commercialize CARDAMYST™ (Etripamil) Nasal Spray in Greater China
SHANGHAI, March 23, 2026 /PRNewswire/ -- Everest Medicines (HKEX 1952.HK, "Everest", or the "Company"), a biopharmaceutical company focused on the discovery, clinical development, manufacturing, and commercialization of innovative therapeutics,...
Everest Medicines Enters into Letter of Intent with Hasten Biopharmaceuticals (Asia) Limited
SHANGHAI, March 18, 2026 /PRNewswire/ -- Everest Medicines (HKEX 1952.HK, "Everest", or the "Company"), a biopharmaceutical company focused on the discovery, clinical development, manufacturing, and commercialization of innovative therapeutics,...
Breakthrough at 2026 AACR! Senhwa Biosciences' CX-5461 Enters the Field of Photodynamic Therapy, Opening a New Indication Strategy
TAIPEI and SAN DIEGO, March 18, 2026 /PRNewswire/ -- Senhwa Biosciences, Inc. (TPEx: 6492), a clinical stage company focusing on development of first-in-class therapeutics for oncology, rare diseases, and infectious diseases, today announced that...
XCL Education Enters Thailand's Eastern Economic Corridor with Mooltripakdee Partnership
SINGAPORE and PATTAYA, Thailand, March 17, 2026 /PRNewswire/ -- XCL Education ("XCL"), one of Southeast Asia's leading K-12 education platforms, has entered a strategic partnership with Mooltripakdee International School (MIS) in Chonburi, Thailand...
Akeso Announces Global First-in-Class Trispecific Antibody AK150 Enters Clinical Trials: A Triple-Target Approach to Overcome Immunotherapy Resistance
HONG KONG, March 16, 2026 /PRNewswire/ -- Akeso, Inc. (9926.HK) ("Akeso" or the "Company") announced today that its proprietary first-in-class trispecific antibody, AK150 (ILT2/ILT4/CSF1R), has received Investigational New Drug (IND) clearance from...
World's First Self-Balancing Motorcycle OMO X Enters Mass Production: A New Era for Smart Two-Wheelers
SINGAPORE, March 13, 2026 /PRNewswire/ -- At the 2026 Global Technology Launch held at Jewel Changi Airport's Canopy Park, OMOWAY announced that its flagship self-balancing electric motorcycle, the OMO X, has officially entered mass production, with...